How do you ensure the mask doesn't fall off in general circulation?

Stability is paramount. Our linkers are engineered to be highly stable against ubiquitous proteases. We conduct extensive stability assays in research media to ensure the "lock" remains secure until it encounters the specific enzymatic profile of the target area.

Can this service be applied to existing antibody sequences?

Absolutely. Our platform is compatible with almost any IgG-based scaffold. We can adapt your existing leads into a masked format with minimal changes to the core sequence.

Ab Lock Masking Service - Creative Biolabs

Ab Lock Masking Service

Creative Biolabs utilizes a sophisticated recombinant engineering architecture to synthesize sequestered antibodies for investigative use. By integrating protease-sensitive linkers with high-affinity masking domains, the platform generates biologic candidates that maintain systemic quiescence. Activation occurs only upon encounter with target-specific enzymatic catalysts, providing a robust resolution to off-target reactivity challenges. Consequently, investigators access lead candidates with enhanced specificity, allowing them to bypass traditional toxicity thresholds. These tools enable the secure evaluation of antigens with broad expression profiles within early-stage development models.

Introduction What We Can Offer How We Can Help Why Creative Biolabs Customer Review FAQs Related Services Contact Us

The MOA of Ab Lock

Monoclonal antibodies are a cornerstone of modern research, yet systemic antigen neutralization often triggers complications in discovery models. Ab lock masking technology addresses this by generating protease-cleavable Pro-antibodies. Literature confirms that masking domains effectively shield antigen-binding sites in non-target environments, selectively "turning on" activity only in protease-overexpressed targeted areas. This strategy is essential for maximizing the specificity window and expanding the reach of targeted therapy research to high-risk antigens.

Fig.1 Schematic of pro-antibody selectively activated at the disease region by installing a protease-cleavable Ab lock. (OA Literature)

Fig.1 Schematic diagram of the MOA of pre-antibody in the diseased area by installing protease-cleavable Ab lock. ¹

What We Can Offer

Bespoke Design of Masking Architectures

We facilitate the tailored synthesis of affinity-peptide or steric-hindrance modalities, such as coiled-coil or LAP locks, precisely engineered to complement the unique CDR topography of your parental antibody for successful paratope sequestration.

Structure-Guided Computational Optimization

Our team employs high-resolution molecular dynamics simulations to achieve maximal masking efficiency. This iterative process ensures that paratope occlusion does not compromise the inherent stability or the developability of the protein scaffold during discovery.

Integrated Mammalian Expression Systems

We provide a robust pathway for the production of engineered molecules. This workflow ensures a seamless transition from small-scale pilot expression to large-scale research fermentation in high-yield systems for pre-clinical evaluation.

Quantitative Analytical Validation

Precision is quantified through rigorous biophysical characterization. By utilizing SPR (Biacore), HPLC, and mass spectrometry, we verify masking ratios and enzymatic activation rates with high clarity to support your experimental data.

How Creative Biolabs' service Can Assist Your Projects

Highlights

Distinguished Proficiency in Recombinant Design

Creative Biolabs maintains a leading position in the field of advanced antibody modification. Our methodology transcends conventional predictive models by integrating empirical engineering. This approach ensures that each recombinant molecule adheres to the most stringent criteria for structural and functional fidelity.

Versatile Modalities for Paratope Sequestration

We employ a unique dual-strategy framework that utilizes both steric-hindrance and affinity-peptide designs. This operational flexibility allows our scientists to identify the most effective mechanism for the site-specific sequestration of your antibody's paratope.

Attenuation of Immunogenic Liability

By effectively shielding the paratope during systemic circulation, our platform significantly reduces the induction of anti-idiotypic responses. This sequestration ensures the acquisition of clearer data. Furthermore, it enhances the predictability of experimental outcomes within pre-clinical models.

Empirically Validated Affinity Modulation

Utilizing peer-reviewed data as benchmarks, we routinely achieve masking efficiencies representing a reduction in systemic affinity. Perhaps this rigorous validation process is essential. We speculate that it is the only way to guarantee that lead candidates maintain their site-specific activation potential.

Discover how a partnership with us can streamline your research - Get a quote today.

Customer Reviews

FAQs

Related Services

ADC Antibody Screening Service

This service encompasses a comprehensive screening platform for antibody internalization and payload potency, facilitating the systematic identification and optimization of high-affinity candidates tailored for site-specific therapeutic delivery.

Learn More →

Bispecific Antibody Engineering

This platform enables the custom design and production of dual-targeting antibodies, utilizing diverse structural formats to enhance synergistic binding and biological efficacy across varied therapeutic research applications.

Learn More →

How to Contact Us

Creative Biolabs provides the technological bridge between potent antibody design and research safety. By leveraging advanced structural biology and site-specific proteolytic activation, we help you overcome the limitations of "on-target, off-site" interaction. We rejuvenate your biotherapeutic discovery pipeline. Please feel free to contact us for more information about our services.